Morgan Stanley Funds (UK) - US Advantage Fund

Select share classes
There is only one type of share class for this fund.

Morgan Stanley Funds (UK) - US Advantage Fund I Hedged Accumulation GBP

Category Other Equity


This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price

£12.9986

arrow-down£-0.394 (-2.94%)

Fund Code

MSUIA

BK0WFX3

GB00BK0WFX38

Prices updated as at 15 Nov 2024
|
Prices in GBP

Investment objective
The Fund’s aim is to grow investor's investment over 3 – 5 years. The Fund invests at least 80% of its assets in securities issued by US companies.

Annual charges

Product charges
0.85
0.48
No
-
0.00
0.00
Minimum investment25.00

Documents

Document nameDate postedDownload
Annual Reports 31 Mar 2024pdf
Annual Short Report 31 Mar 2024pdf
Interim Short Report 31 Mar 2024pdf
Key Information Document / Technical Guide 19 Feb 2024pdf
Please note that service charges will also apply. Read more about our fees.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2024 Morningstar. All rights reserved.